tdf

Listen to Roger Bedimo, MD, MS, FACP, discuss considerations for older people living with HIV, including:

• Polypharmacy and deprescribing
• The risk of cardiovascular events with various ART regimens
• Approaches for managing weight gain

Presenter:

Roger Bedimo, MD, MS, FACP
Professor of Medicine
Interim Director, Office of Global Health
UT Southwestern Medical Center
Chief, Infectious Diseases Section
VA North Texas Health Care System
Dallas, Texas

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

To download the slides: 
 https://bit.ly/49zrnZs

To view the full online program:
https://bit.ly/49x0W6D

In this episode, Tavell L. Kindall, PhD, DNP, ARNP, FNP-BC, AACRN, AAHIVS, FAANP, and Anne Teitelman, PhD, FNP-BC, FANNP, FAAN, discuss key PrEP considerations for advanced practice providers in primary care settings, including: 

• The importance of having PrEP navigators to help with logistics and be a point of contact for patients 
• Where to find education and resources to familiarize yourself with PrEP and its prescribing
• Safety considerations and adverse events associated with PrEP options
• PrEP coverage and cost
• How to discontinue PrEP and the risk of resistance if someone acquires HIV while taking PrEP

Faculty

Tavell L. Kindall, PhD, DNP, ARNP, FNP-BC, AACRN, AAHIVS, FAANP
Director, HIV Prevention and Treatment
St. Thomas Community Health Center
New Orleans, Louisiana

Anne Teitelman, PhD, FNP-BC, FANNP, FAAN
Associate Professor Emeritus of Nursing and Global Women’s Health
Department of Family and Community Health
School of Nursing
University of Pennsylvania
Professor
Thomas Jefferson University
College of Nursing
Philadelphia, Pennsylvania

Link to full program: 
https://bit.ly/3PZGYdR

In this episode, Dr Tavell Kindall and Jona Tanguay discuss actionable strategies for advanced practice providers to increase the frequency at which PrEP is offered and initiated in primary care settings. Topics covered include:

• Available training resources on how to offer PrEP in primary care
• Affordable, accessible PrEP options, including patient assistance programs
• Using electronic health records to identify candidates for PrEP
• Opportunities to offer PrEP during appointments regarding birth control, STIs, or any other sexual health concerns
• How to offer 3-site STI testing at your facility
• Wrapping PrEP into primary care
• Incorporating navigators or care coordinators to reduce logistical barriers and reach underserved populations
• Rapid testing, mobile testing, and Tele-PrEP as ways to facilitate PrEP initiation and simplify routine PrEP visits
• Healthcare professionals’ personal biases as a potential barrier to PrEP
• Using ICD-10 codes for HIV PrEP as a way to further destigmatize PrEP and simplify billing

Faculty:

Tavell L. Kindall, PhD, DNP, ARNP, FNP-BC, AACRN, AAHIVS, FAANP
Director, HIV Prevention and Treatment
St. Thomas Community Health Center
New Orleans, Louisiana

Jona Tanguay, MMSc, PA-C, AAHIVS
Medical Program Lead - Substance Use Disorders at Whitman-Walker Health
Associate Medical Director - Transgender Health at Amida Care
President-Elect at GLMA: Health Professionals Advancing LGBTQ+ Equality
Clinical Instructor at Yale School of Medicine
Founder at ChemsexHarmReduction.org
Washington, DC

Content is supported by independent educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Link to full program: 
https://bit.ly/3PZGYdR

In this episode, Errol L. Fields, MD, PhD, MPH, and Armonté Butler, MPH, a pre-exposure prophylaxis (PrEP) advocate, discuss strategies for overcoming barriers to uptake of PrEP for HIV in adolescents and young adults, based on the unique needs of this patient population. Topics covered include:

• Methods for building trust between patients and providers
• Ways to practice shared decision-making and how this process hinges on respecting patients’ autonomy and personhood
• How to empower young people to ask for the assistance they need
• How to navigate consent and confidentiality issues
• Information about payment options
• Strategies to improve adherence for youth
• The best ways to provide support and flexibility throughout this process to promote persistence on PrEP

Faculty:

Errol L. Fields, MD, PhD, MPH
Associate Professor of Pediatrics
Division of Adolescent/Young Adult Medicine
Department of Pediatrics
Johns Hopkins School of Medicine
Baltimore, Maryland

Armonté Butler, MPH
Associate Director, LGBTQ Health & Rights
Advocates for Youth
Washington, DC

Content is supported by independent educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Link to full program: 
https://bit.ly/3PZGYdR

In this podcast, experts Sarah M. Wood, MD, MS, and Errol L. Fields, MD, PhD, MPH, discuss some of the challenges and concerns clinicians face when prescribing PrEP to adolescents. 

The faculty addresses the potential for adverse effects from PrEP, including the potential for renal impairment, decreased bone density, and whether PrEP can interfere with hormone therapy for gender-affirming care. They review the data behind these concerns and emphasize that the vast majority of adverse effects caused by PrEP are mild and reversible.

The experts also examine common barriers that adolescents face when attempting to initiate and adhere to PrEP, such as insurance coverage and confidentiality. Dr Fields and Dr Woods discuss strategies for overcoming these barriers and retaining adolescents on PrEP, including how to navigate tricky conversations with both patients and parents or within communities that may stigmatize PrEP and HIV.

Sarah M. Woods, MD, MS
Assistant Professor of Pediatrics
Division of Adolescent Medicine
University of Pennsylvania Perelman School of Medicine
Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania

Errol L. Fields, MD, PhD, MPH
Associate Professor of Pediatrics
Division of Adolescent/Young Adult Medicine
Department of Pediatrics
Johns Hopkins School of Medicine
Baltimore, Maryland

Content based on an online CME program supported by independent educational grants from Gilead Sciences Inc. and ViiV Healthcare.

Link to full program: 
https://bit.ly/3PZGYdR

In this episode, Joseph Ahn, MD, MS, MBA; Christina Delacruz Leyson, MD; and Alice Chan, a person who experienced pregnancy as a person living with chronic hepatitis B, discuss solutions for overcoming barriers to HBV care in people of childbearing potential and their infants, including:

• HBV screening and vaccination in pregnancy
• Management of pregnant people who are HBsAg positive
• Infant care
• Breastfeeding

Presenters: 

Joseph Ahn, MD, MS, MBA
Professor of Medicine, Section Chief
Division of Gastroenterology and Hepatology
Oregon Health & Science University
Portland, Oregon

Christina Delacruz Leyson, MD
Associate Professor
Medical Director, Liver Transplant Program
Program Director, Hepatology Fellowship
University of Kentucky
Lexington, Kentucky

Alice Chan, person living with chronic hepatitis B

Link to downloadable slides:
https://bit.ly/3rXLTC7

Link to program: 
https://bit.ly/3L3Kz6l

In this episode, Robert S. Brown, Jr., MD, MPH; Nancy Reau, MD; and Eric, a person living with chronic hepatitis B, discuss solutions for overcoming barriers to HBV care in older adults, including:

• Awareness of HBV and CHB in older adults
• Updated HBV screening and vaccination recommendations
• Monitoring of renal and bone disease
• Adjustment of monitoring and treatment as a person with HBV ages

Presenters: 
Robert S. Brown, Jr., MD, MPH
Vincent Astor Distinguished 
Professor of Medicine
Chief, Division of Gastroenterology and Hepatology
Weill Cornell Medicine
New York, New York

Nancy Reau, MD
Professor of Medicine
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Richard B. Capps Chair of Hepatology
Rush University Medical Center
Chicago, Illinois

Eric, person living with chronic hepatitis B

Link to downloadable slides: please link to VM404 downloadable slides when ready

Link to program: 
bit.ly/3L3Kz6l

In this episode, Maunank Shah, MD, PhD, discusses using HIV-ASSIST to optimize treatment for both HIV and hyperlipidemia. Listen as he covers:

• Hyperlipidemia and cardiovascular disease risk among people living with HIV
• Recommendations for lipid screening for people living with HIV
• Using HIV-ASSIST to support ART treatment decisions for people living with HIV with comorbidities
• How HIV-ASSIST prioritizes certain ART agents in the setting of hyperlipidemia, including:
  • Deciding between bictegravir, doravirine, dolutegravir, raltegravir, and rilpivirine vs boosted protease inhibitors, including darunavir
  • Deciding between tenofovir disoproxil fumarate and tenofovir alafenamide or abacavir
• How HIV-ASSIST incorporates drug‒drug interaction data from the University of Liverpool HIV Drug Interactions Checker and the DHHS guidelines when considering the use of statin therapy with ART
• How HIV-ASSIST further incorporates drug resistance data from the Stanford HIV Drug Resistance Database

Maunank Shah, MD, PhD 
Associate Professor 
Infectious Diseases 
Johns Hopkins University 
Baltimore, Maryland 

Link to full program: bit.ly/3pwaH2Y

In this episode, Carolyn Chu, MD, MSc, FAAFP, AAHIVS, discusses using HIV-ASSIST to aid in the selection of an ART regimen for PWH coinfected with HBV and HCV. Listen as she covers:

• How HIV-ASSIST supports ART selection in primary care
• Updates to viral hepatitis recommendations including:  
•              CDC HBV screening and testing recommendations
•              AASLD simplified HCV treatment approach for PWH
• HIV-ASSIST for managing HIV/HBV coinfections, including ensuring that NRTIs that are effective for both HIV and HBV are included in an ART regimen and alerting the user when an additional HBV treatment is needed 
• HIV-ASSIST for managing HIV/HCV coinfections, including showing how the HIV-ASSIST tool incorporates drug‒drug interaction considerations from the University of Liverpool HIV Drug Interaction Checker

Carolyn Chu, MD, MSc, FAAFP, AAHIVS
Chief Clinical Officer
National Clinician Consultation Center
Professor
Clinical Family Community Medicine
University of California, San Francisco
San Francisco, California

Link to full program: bit.ly/3pwaH2Y

In this episode, Christine Katlama, MD, and Babafemi Taiwo, MBBS, discuss optimizing ART for people with HIV who are treatment experienced or failing a current ART regimen, including:

• Recycling agents from the NRTI, NNRTI, INSTI, and PI classes in salvage ART regimens
• Maintaining NRTIs in second-line and salvage ART regimens, including the use of 3TC, TFV, and ABC
• ART regimen simplification
• When to perform genotypic resistance testing, including for PWH who have been off ART
• When to perform DNA genotyping for archived resistance testing
• Considering LA CAB + RPV with prior NNRTI exposure, ART resistance, or past adherence concerns with oral ART
• Using boosted DRV + DTG in salvage regimens
• Switching from boosted PIs to INSTIs in PWH receiving second-line therapy
• Second-line regimens with LA CAB + RPV failure 

Christine Katlama, MD 
Professor 
Sorbonne University APHP Paris 
Head, HIV/Hepatitis Clinical and Research Unit 
Department of Infectious Diseases 
Paris, France 

Babafemi Taiwo, MBBS 
Gene Stollerman Professor of Medicine 
Chief, Division of Infectious Diseases 
Northwestern University Feinberg School of Medicine 
Chicago, Illinois 

Link to full program: https://bit.ly/3Z44Gq3

In this episode, Daniel R. Kuritzkes, MD, discusses considerations for patients experiencing weight gain on antiretroviral therapy, including:

• Commonly implicated antiretroviral therapy regimens and patient populations

• Guideline recommendations for management of weight gain

Presenter:

Daniel R. Kuritzkes, MD
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Chief, Division of Infectious Diseases
Brigham and Women’s Hospital
Boston, Massachusetts

To download the slides: 
bit.ly/3odUA9C

To view the full online program: 
bit.ly/3ZjSFhg